Metformin, the most widely prescribed anti-diabetic drug, is usually shown to possess anti-cancer potential in treatment of cancers, including breast malignancy; decreases breast malignancy risk; and improves overall survival
Metformin, the most widely prescribed anti-diabetic drug, is usually shown to possess anti-cancer potential in treatment of cancers, including breast malignancy; decreases breast malignancy risk; and improves overall survival. to metastatic progression and development of resistance to chemotherapy/radiotherapy. Our studies were performed in two different types of TNBCs, MDA-MB-231 cells (mesenchymal stem cell-like (MSL)) and … [Read more…]